More than a decade ago, Yale chemist Craig Crews founded a biotechnology company in New Haven based on his pioneering ...
The difference between an anomaly and a defect in product software can be confusing, but it is important to identify which is ...
The Food and Drug Administration’s flagship internal AI tool, Elsa, is being integrated with the data platform so that staff ...
The US Food and Drug Administration (FDA) has issued warning letters to several firms that have violated current good ...
Texas is helping shape the future of psychedelic therapies. Here’s how they work and what access could look like.
NOTICE: The project that is the subject of this report was approved by the Governing Board of the National Research Council, whose members are drawn from the councils of the National Academy of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results